CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 30 filers reported holding CASI PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $91,000 | +40.0% | 112,777 | +39.6% | 0.01% | 0.0% |
| Q4 2021 | $65,000 | +80.6% | 80,806 | +164.4% | 0.01% | +133.3% |
| Q3 2021 | $36,000 | -77.4% | 30,560 | -53.8% | 0.00% | -72.7% |
| Q1 2021 | $159,000 | +329.7% | 66,106 | +431.0% | 0.01% | +175.0% |
| Q4 2020 | $37,000 | -37.3% | 12,450 | -67.7% | 0.00% | -60.0% |
| Q3 2020 | $59,000 | +51.3% | 38,496 | +217.5% | 0.01% | +400.0% |
| Q4 2017 | $39,000 | -45.8% | 12,124 | -70.3% | 0.00% | -50.0% |
| Q3 2017 | $72,000 | – | 40,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 951,064 | $7,827,000 | 4.06% |
| Wellington Shields Capital Management, LLC | 855,056 | $7,037,000 | 1.16% |
| Manatuck Hill Partners, LLC | 15,090 | $124,000 | 0.05% |
| Moors & Cabot, Inc. | 22,935 | $187,000 | 0.02% |
| Perceptive Advisors | 43,682 | $360,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 120,000 | $988,000 | 0.01% |
| ALPS ADVISORS INC | 125,015 | $1,029,000 | 0.01% |
| MetLife Investment Management, LLC | 26,316 | $217,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 136,518 | $1,124,000 | 0.00% |
| Private Advisor Group, LLC | 15,001 | $122,000 | 0.00% |